Literature DB >> 29954240

EGFR activation induced Snail-dependent EMT and myc-dependent PD-L1 in human salivary adenoid cystic carcinoma cells.

Yang Wang1,2,3, Jingzhou Hu1,2,3, Yan'an Wang1,2,3, Weimin Ye1,2,3, Xiangkai Zhang1,2,3, Houyu Ju1,2,3, Dongliang Xu4, Liu Liu1,2,3, Dongxia Ye1,2,3, Ling Zhang1,2,3, Dongwang Zhu1,2,3, Jiong Deng4, Zhiyuan Zhang1,2,3, Shuli Liu1,2,3.   

Abstract

Epithelial-to-mesenchymal transition (EMT) confers cancer cells the ability of invasion and metastasis. However, how does EMT contribute to evasion of immune surveillance is unclear, especially in salivary adenoid cystic carcinoma (SACC). In this study, we investigated the molecular link between EGF-induced EMT and the immune checkpoint ligand programmed death-ligand 1 (PD-L1) by immunoprecipitation (IP) and Westernblot analysis. Cell migration and invasion activity was assayed by transwell assay. Immunohistochemical (IHC) staining analysis was performed for measurement of EMT markers and PD-L1 expression levels in tumor tissues. We found that EGF-induced EGFR activation stabilized Snail expression and induced EMT in SACC. Interestingly, EGFR activation induced simultaneously both EMT and PD-L1 in SACC. Importantly, knockdown of Snail greatly suppressed EGF-induced EMT, but not EGF-induced PD-L1 expression; whereas knockdown of c-Myc strongly repressed PD-L1 expression, but not snail expression and EMT. The molecular link is strongly supported by robust correlations between the EMT markers and PD-L1 expression in human cancer samples.These results suggest that EGFR activated EMT and PD-L1 via two distinct mechanisms. EGFR activation induced EMT and PD-L1 expression in SACC. Snail is required for EGF-induced EMT, but not PD-L1 expression; whereas c-Myc is required for EGFR-mediated PD-L1 upregulation but not EMT. Thus, targeting activated EGFR may inhibit both EMT and PD-L1, which may potentiate the therapeutic effect of PD-L1-based immunotherapy, especially in the malignant subgroups of SACC patients with activated EGFR.

Entities:  

Keywords:  EMT; PD-L; SACC; Snail; c-Myc

Mesh:

Substances:

Year:  2018        PMID: 29954240      PMCID: PMC6132955          DOI: 10.1080/15384101.2018.1489177

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  44 in total

Review 1.  Cancer immunoediting: from immunosurveillance to tumor escape.

Authors:  Gavin P Dunn; Allen T Bruce; Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

Review 2.  Adenoid cystic carcinoma of the head and neck--An update.

Authors:  Andrés Coca-Pelaz; Juan P Rodrigo; Patrick J Bradley; Vincent Vander Poorten; Asterios Triantafyllou; Jennifer L Hunt; Primož Strojan; Alessandra Rinaldo; Missak Haigentz; Robert P Takes; Vanni Mondin; Afshin Teymoortash; Lester D R Thompson; Alfio Ferlito
Journal:  Oral Oncol       Date:  2015-05-02       Impact factor: 5.337

3.  Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance.

Authors:  Michelle D Williams; Dianna B Roberts; Merrill S Kies; Li Mao; Randal S Weber; Adel K El-Naggar
Journal:  Clin Cancer Res       Date:  2010-04-06       Impact factor: 12.531

4.  Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

Authors:  Suzanne L Topalian; F Stephen Hodi; Julie R Brahmer; Scott N Gettinger; David C Smith; David F McDermott; John D Powderly; Richard D Carvajal; Jeffrey A Sosman; Michael B Atkins; Philip D Leming; David R Spigel; Scott J Antonia; Leora Horn; Charles G Drake; Drew M Pardoll; Lieping Chen; William H Sharfman; Robert A Anders; Janis M Taube; Tracee L McMiller; Haiying Xu; Alan J Korman; Maria Jure-Kunkel; Shruti Agrawal; Daniel McDonald; Georgia D Kollia; Ashok Gupta; Jon M Wigginton; Mario Sznol
Journal:  N Engl J Med       Date:  2012-06-02       Impact factor: 91.245

Review 5.  Inflammation: a driving force speeds cancer metastasis.

Authors:  Yadi Wu; Binhua P Zhou
Journal:  Cell Cycle       Date:  2009-10-03       Impact factor: 4.534

6.  B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma.

Authors:  Scott E Strome; Haidong Dong; Hideto Tamura; Stephen G Voss; Dallas B Flies; Koji Tamada; Diva Salomao; John Cheville; Fumiya Hirano; Wei Lin; Jan L Kasperbauer; Karla V Ballman; Lieping Chen
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

7.  Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells.

Authors:  Chie Kudo-Saito; Hiromi Shirako; Tadashi Takeuchi; Yutaka Kawakami
Journal:  Cancer Cell       Date:  2009-03-03       Impact factor: 31.743

8.  Clinicopathologic predictors and impact of distant metastasis from adenoid cystic carcinoma of the head and neck.

Authors:  Myung-Whun Sung; Kwang Hyun Kim; Jeong-Whun Kim; Yang-Gi Min; Weon-Jin Seong; Jong-Lyel Roh; Sang Joon Lee; Tack-Kyun Kwon; Seok Woo Park
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2003-11

9.  SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions.

Authors:  Cindy Vandewalle; Joke Comijn; Bram De Craene; Petra Vermassen; Erik Bruyneel; Henriette Andersen; Eugene Tulchinsky; Frans Van Roy; Geert Berx
Journal:  Nucleic Acids Res       Date:  2005-11-24       Impact factor: 16.971

10.  High Vimentin Expression Associated with Lymph Node Metastasis and Predicated a Poor Prognosis in Oral Squamous Cell Carcinoma.

Authors:  Shuli Liu; Liu Liu; Weimin Ye; Dongxia Ye; Tong Wang; Wenzheng Guo; Yueling Liao; Dongliang Xu; Hongyong Song; Ling Zhang; Hanguang Zhu; Jiong Deng; Zhiyuan Zhang
Journal:  Sci Rep       Date:  2016-12-14       Impact factor: 4.379

View more
  15 in total

Review 1.  Emerging role of tumor cell plasticity in modifying therapeutic response.

Authors:  Siyuan Qin; Jingwen Jiang; Yi Lu; Edouard C Nice; Canhua Huang; Jian Zhang; Weifeng He
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

Review 2.  Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation.

Authors:  Mengling Wu; Qianrui Huang; Yao Xie; Xuyi Wu; Hongbo Ma; Yiwen Zhang; Yong Xia
Journal:  J Hematol Oncol       Date:  2022-03-12       Impact factor: 17.388

3.  Polydatin Inhibits Cell Viability, Migration, and Invasion Through Suppressing the c-Myc Expression in Human Cervical Cancer.

Authors:  Longchang Bai; Yingkang Ma; Xue Wang; Qiongni Feng; Zhining Zhang; Sijie Wang; Huijie Zhang; Xinyu Lu; Yonghui Xu; Erhu Zhao; Hongjuan Cui
Journal:  Front Cell Dev Biol       Date:  2021-04-12

4.  The immunophenotype of epithelial to mesenchymal transition inducing transcription factors in salivary gland adenoid cystic carcinomas.

Authors:  Iulia Cristiana Belulescu; Claudiu Mărgăritescu; Cristiana Iulia Dumitrescu; Maria Cristina Munteanu; Luminiţa Dăguci; Otilia Clara Mărgăritescu; Marius Matei
Journal:  Rom J Morphol Embryol       Date:  2020 Jul-Sep       Impact factor: 1.033

Review 5.  Controversies around epithelial-mesenchymal plasticity in cancer metastasis.

Authors:  Elizabeth D Williams; Dingcheng Gao; Andrew Redfern; Erik W Thompson
Journal:  Nat Rev Cancer       Date:  2019-10-30       Impact factor: 60.716

Review 6.  Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape.

Authors:  Xianjie Jiang; Jie Wang; Xiangying Deng; Fang Xiong; Junshang Ge; Bo Xiang; Xu Wu; Jian Ma; Ming Zhou; Xiaoling Li; Yong Li; Guiyuan Li; Wei Xiong; Can Guo; Zhaoyang Zeng
Journal:  Mol Cancer       Date:  2019-01-15       Impact factor: 27.401

Review 7.  Spatial and Temporal Changes in PD-L1 Expression in Cancer: The Role of Genetic Drivers, Tumor Microenvironment and Resistance to Therapy.

Authors:  Elena Shklovskaya; Helen Rizos
Journal:  Int J Mol Sci       Date:  2020-09-27       Impact factor: 5.923

8.  Isolation and Characterization of Two Novel Colorectal Cancer Cell Lines, Containing a Subpopulation with Potential Stem-Like Properties: Treatment Options by MYC/NMYC Inhibition.

Authors:  Jan Schulte Am Schulte Am Esch; Beatrice Ariane Windmöller; Johannes Hanewinkel; Jonathan Storm; Christine Förster; Ludwig Wilkens; Martin Krüger; Barbara Kaltschmidt; Christian Kaltschmidt
Journal:  Cancers (Basel)       Date:  2020-09-10       Impact factor: 6.639

9.  The EGFR-P38 MAPK axis up-regulates PD-L1 through miR-675-5p and down-regulates HLA-ABC via hexokinase-2 in hepatocellular carcinoma cells.

Authors:  Zongcai Liu; Fen Ning; Yanna Cai; Huiying Sheng; Ruidan Zheng; Xi Yin; Zhikun Lu; Ling Su; Xiaodan Chen; Chunhua Zeng; Haifang Wang; Li Liu
Journal:  Cancer Commun (Lond)       Date:  2021-01-01

10.  Immune checkpoint molecules are regulated by transforming growth factor (TGF)-β1-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma.

Authors:  Ritu Shrestha; Kim R Bridle; Darrell H G Crawford; Aparna Jayachandran
Journal:  Int J Med Sci       Date:  2021-04-22       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.